BioCardia, Inc. (BCDA) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 114 transactions totaling $15.2M, demonstrating a bullish sentiment with $10.1M in net insider flow. The most recent transaction on Feb 4, 2026 involved a purchase of 5,000 shares valued at $5.7K.
No significant insider buying has been recorded for BCDA in the recent period.
No significant insider selling has been recorded for BCDA in the recent period.
Based on recent SEC filings, insider sentiment for BCDA is bullish with an Insider Alignment Score of 83/100 and a net flow of $10.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at BioCardia, Inc. (BCDA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading BCDA stock, having executed 114 transactions in the past 90 days. The most active insider is Simon H. Stertzer (Executive), who has made 26 transactions totaling $9.6M.
Get notified when executives and directors at BCDA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Altman Peter | Executive | Purchase | 5,000 | $1.13 | $5.7K | |
| Jan 21, 2026 | Altman Peter | Executive | Purchase | 300 | $1.34 | $402 | |
| Jan 20, 2026 | Altman Peter | Executive | Purchase | 600 | $1.32 | $792 | |
| Dec 17, 2025 | Altman Peter | Executive | Purchase | 900 | $1.30 | $1.2K | |
| Dec 16, 2025 | Altman Peter | Executive | Purchase | 200 | $1.37 | $274 | |
| Dec 8, 2025 | M. Gillis Edward | Executive | Payment | 15,172 | $1.37 | $20.8K | |
| Dec 8, 2025 | M. Gillis Edward | Executive | Award | 38,078 | $1.37 | $52.2K | |
| Dec 8, 2025 | Mcclung David | Executive | Award | 58,276 | $1.37 | $79.8K | |
| Dec 8, 2025 | Mcclung David | Executive | Payment | 29,339 | $1.37 | $40.2K | |
| Dec 8, 2025 | Altman Peter | Executive | Award | 106,588 | $1.37 | $146.0K | |
| Dec 8, 2025 | Altman Peter | Executive | Payment | 56,484 | $1.37 | $77.4K | |
| Sep 19, 2025 | Altman Peter | Executive | Purchase | 48,000 | $1.25 | $60.0K | |
| Sep 19, 2025 | Scott Blank Andrew | Executive | Purchase | 288,000 | $1.25 | $360.0K | |
| Sep 19, 2025 | H. Stertzer Simon | Executive | Purchase | 398,400 | $1.25 | $498.0K | |
| Aug 22, 2025 | Altman Peter | Executive | Purchase | 700 | $1.83 | $1.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 89 | $12.6M | 75.7% |
Sale(S) | 2 | $2.6M | 15.3% |
Award(A) | 7 | $911.0K | 5.5% |
Exercise(M) | 12 | $244.6K | 1.5% |
Conversion(C) | 1 | $202.5K | 1.2% |
Payment(F) | 3 | $138.4K | 0.8% |
Insiders at BioCardia, Inc. are accumulating shares at an accelerated pace. With 13 insiders making 114 transactions totaling $12.6M in purchases versus $2.6M in sales, the net buying activity of $10.1M signals strong executive confidence. Simon H. Stertzer (Executive) leads the buying activity with $9.6M in transactions across all time.